Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

A capital conference: Influencing epigenetic mechanisms may be highly relevant for future therapies of various diseases such as cancer, inflammation, and metabolic disorders. Leading experts in the field gathered in Berlin on June 5-6, 2013 at a Bayer HealthCare Life Science Workshop to share recent success stories and to discuss future trends.

Original publication

DOI

10.1002/cmdc.201300344

Type

Journal article

Journal

ChemMedChem

Publication Date

11/2013

Volume

8

Pages

1885 - 1891

Keywords

bromodomains, cancer, chemical probes, epigenetic targets, histone methyltransferase, inhibitors, Drug Delivery Systems, Epigenesis, Genetic, Histone-Lysine N-Methyltransferase, Humans, Molecular Structure, Small Molecule Libraries